Drotebanol

Identification

Name
Drotebanol
Accession Number
DB01547
Type
Small Molecule
Groups
Experimental, Illicit
Description
Not Available
Structure
Thumb
Synonyms
Not Available
External IDs
IDS-ND-018
Categories
UNII
7RS2Q8MCK8
CAS number
3176-03-2
Weight
Average: 333.422
Monoisotopic: 333.194008357
Chemical Formula
C19H27NO4
InChI Key
LCAHPIFLPICNRW-SVYNMNNPSA-N
InChI
InChI=1S/C19H27NO4/c1-20-9-8-18-11-13(21)6-7-19(18,22)15(20)10-12-4-5-14(23-2)17(24-3)16(12)18/h4-5,13,15,21-22H,6-11H2,1-3H3/t13-,15-,18-,19-/m1/s1
IUPAC Name
(1R,9R,10S,13R)-3,4-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-10,13-diol
SMILES
[H][[email protected]]12CC3=C(C(OC)=C(OC)C=C3)[[email protected]@]3(CCN1C)C[[email protected]](O)CC[[email protected]@]23O

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
7-NitroindazoleThe risk or severity of adverse effects can be increased when Drotebanol is combined with 7-Nitroindazole.Experimental
7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineThe risk or severity of adverse effects can be increased when Drotebanol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.Experimental
AcepromazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Acepromazine.Approved, Vet Approved
AceprometazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Aceprometazine.Approved
AdipiplonThe risk or severity of adverse effects can be increased when Drotebanol is combined with Adipiplon.Investigational
AgomelatineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Agomelatine.Approved, Investigational
AlaproclateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Alaproclate.Experimental
AlfaxaloneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Alfaxalone.Vet Approved
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Drotebanol.Approved, Illicit
AllopregnanoloneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Allopregnanolone.Investigational
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Alphacetylmethadol.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Alphaprodine.Illicit
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Drotebanol.Approved, Illicit, Investigational
AmisulprideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Amisulpride.Approved, Investigational
AmitriptylineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Amitriptyline.Approved
AmobarbitalThe risk or severity of adverse effects can be increased when Amobarbital is combined with Drotebanol.Approved, Illicit
AmoxapineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Amoxapine.Approved
AmperozideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Amperozide.Experimental
AmphetamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Amphetamine.Approved, Illicit
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Drotebanol.Approved, Investigational
ArticaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Articaine.Approved
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Drotebanol.Approved
AzaperoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Azaperone.Investigational, Vet Approved
AzelastineDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.Approved
BaclofenThe risk or severity of adverse effects can be increased when Drotebanol is combined with Baclofen.Approved
BarbitalThe risk or severity of adverse effects can be increased when Barbital is combined with Drotebanol.Illicit
BenmoxinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Benmoxin.Withdrawn
BenperidolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Benperidol.Investigational
BenzocaineThe risk or severity of adverse effects can be increased when Benzocaine is combined with Drotebanol.Approved
Benzyl alcoholThe risk or severity of adverse effects can be increased when Drotebanol is combined with Benzyl alcohol.Approved
BrexpiprazoleThe risk or severity of adverse effects can be increased when Drotebanol is combined with Brexpiprazole.Approved
BrimonidineBrimonidine may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved
BrofaromineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Brofaromine.Experimental
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Drotebanol.Approved, Illicit
BromisovalThe risk or severity of adverse effects can be increased when Drotebanol is combined with Bromisoval.Experimental
BromperidolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Bromperidol.Investigational
BrompheniramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Brompheniramine.Approved
BrotizolamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Brotizolam.Approved, Investigational, Withdrawn
BupivacaineThe risk or severity of adverse effects can be increased when Bupivacaine is combined with Drotebanol.Approved, Investigational
BuprenorphineDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.Approved, Illicit, Investigational, Vet Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Drotebanol.Approved, Investigational
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Drotebanol.Approved, Illicit
ButacaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Butacaine.Vet Approved
ButalbitalThe risk or severity of adverse effects can be increased when Drotebanol is combined with Butalbital.Approved, Illicit
ButambenThe risk or severity of adverse effects can be increased when Drotebanol is combined with Butamben.Approved
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Drotebanol.Approved, Illicit
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Drotebanol.Approved, Illicit, Vet Approved
CanertinibThe risk or severity of adverse effects can be increased when Drotebanol is combined with Canertinib.Investigational
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Drotebanol.Approved, Investigational
CarbinoxamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Carbinoxamine.Approved
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Drotebanol.Illicit, Investigational, Vet Approved
CarisoprodolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Carisoprodol.Approved
CaroxazoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Caroxazone.Withdrawn
CetirizineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Cetirizine.Approved
Chloral hydrateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Chloral hydrate.Approved, Illicit, Vet Approved
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Drotebanol.Approved, Illicit
ChlormezanoneThe risk or severity of adverse effects can be increased when Chlormezanone is combined with Drotebanol.Approved, Investigational, Withdrawn
ChloroprocaineThe risk or severity of adverse effects can be increased when Chloroprocaine is combined with Drotebanol.Approved
ChlorphenamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Chlorphenamine.Approved
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Drotebanol.Approved, Vet Approved
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Drotebanol.Approved, Investigational, Withdrawn
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Chlorzoxazone.Approved
CinchocaineThe risk or severity of adverse effects can be increased when Cinchocaine is combined with Drotebanol.Approved, Vet Approved
CitalopramThe risk or severity of adverse effects can be increased when Drotebanol is combined with Citalopram.Approved
ClemastineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clemastine.Approved
ClidiniumThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clidinium.Approved
ClobazamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clobazam.Approved, Illicit
clomethiazoleThe risk or severity of adverse effects can be increased when Drotebanol is combined with clomethiazole.Investigational
ClomipramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clomipramine.Approved, Vet Approved
ClonazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clonazepam.Approved, Illicit
ClonidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clonidine.Approved
ClopenthixolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clopenthixol.Experimental
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Drotebanol.Approved, Illicit
ClothiapineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Clothiapine.Experimental
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Drotebanol.Approved
CocaineThe risk or severity of adverse effects can be increased when Cocaine is combined with Drotebanol.Approved, Illicit
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Drotebanol.Approved, Illicit
CyclizineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Cyclizine.Approved
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Drotebanol.Approved
CyproheptadineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Cyproheptadine.Approved
DantroleneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dantrolene.Approved
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Drotebanol.Approved
DapoxetineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dapoxetine.Investigational
DeramciclaneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Deramciclane.Investigational
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Drotebanol.Approved
DesipramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Desipramine.Approved
DesloratadineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Desloratadine.Approved, Investigational
DesvenlafaxineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Desvenlafaxine.Approved
DetomidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Detomidine.Vet Approved
DexbrompheniramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dexbrompheniramine.Approved
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Drotebanol.Approved, Vet Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Drotebanol.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Drotebanol.Approved, Illicit, Investigational, Withdrawn
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Drotebanol.Approved, Investigational
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Drotebanol.Approved, Illicit, Vet Approved
Diethyl etherThe risk or severity of adverse effects can be increased when Drotebanol is combined with Diethyl ether.Experimental
DifenoxinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Difenoxin.Approved, Illicit
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Drotebanol.Approved, Illicit
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Drotebanol.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dihydromorphine.Experimental, Illicit
DimenhydrinateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dimenhydrinate.Approved
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Drotebanol.Approved
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Drotebanol.Approved, Illicit
DixyrazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Dixyrazine.Experimental
DoramectinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Doramectin.Vet Approved
DoxepinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Doxepin.Approved
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when Drotebanol is combined with DPDPE.Experimental
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Illicit
DroperidolDroperidol may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Vet Approved
DuloxetineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Duloxetine.Approved
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Drotebanol.Approved
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Drotebanol.Experimental, Illicit
EcopipamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ecopipam.Investigational
EfavirenzThe risk or severity of adverse effects can be increased when Drotebanol is combined with Efavirenz.Approved, Investigational
EltanoloneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Eltanolone.Investigational
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Drotebanol.Approved, Investigational, Vet Approved
EntacaponeThe risk or severity of adverse effects can be increased when Drotebanol is combined with Entacapone.Approved, Investigational
EscitalopramThe risk or severity of adverse effects can be increased when Drotebanol is combined with Escitalopram.Approved, Investigational
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Drotebanol.Approved, Illicit
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Drotebanol.Approved
EthanolDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.Approved
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Drotebanol.Approved, Illicit, Withdrawn
EthosuximideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ethosuximide.Approved
EthotoinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ethotoin.Approved
Ethyl carbamateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ethyl carbamate.Withdrawn
Ethyl chlorideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ethyl chloride.Experimental, Investigational
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Drotebanol.Approved, Illicit
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Drotebanol.Approved, Illicit
EtidocaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Etidocaine.Approved
EtifoxineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Etifoxine.Investigational, Withdrawn
EtizolamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Etizolam.Approved
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Drotebanol.Approved
EtoperidoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Etoperidone.Withdrawn
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Drotebanol.Illicit, Vet Approved
EzogabineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ezogabine.Approved
FelbamateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Felbamate.Approved
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Drotebanol.Approved, Illicit, Withdrawn
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Drotebanol.Approved, Illicit, Investigational, Vet Approved
FexofenadineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fexofenadine.Approved
FlibanserinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Flibanserin.Approved
FluanisoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fluanisone.Experimental
FludiazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fludiazepam.Approved, Illicit
FlunarizineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Flunarizine.Approved
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Drotebanol.Approved, Illicit
FluoxetineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fluoxetine.Approved, Vet Approved
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Drotebanol.Approved, Withdrawn
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Drotebanol.Approved
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Drotebanol.Approved, Illicit
FluspirileneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fluspirilene.Approved, Investigational
Fluticasone propionateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fluticasone propionate.Approved
FluvoxamineThe risk or severity of adverse effects can be increased when Fluvoxamine is combined with Drotebanol.Approved, Investigational
FosphenytoinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fosphenytoin.Approved
FospropofolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Fospropofol.Approved, Illicit, Investigational
FurazolidoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Furazolidone.Approved, Investigational, Vet Approved
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Drotebanol.Approved, Investigational
Gabapentin EnacarbilThe risk or severity of adverse effects can be increased when Drotebanol is combined with Gabapentin Enacarbil.Approved
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Drotebanol.Approved, Illicit, Investigational
GepironeThe risk or severity of adverse effects can be increased when Drotebanol is combined with Gepirone.Investigational
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Drotebanol.Approved, Illicit
GuanfacineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Guanfacine.Approved, Investigational
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Drotebanol.Approved, Illicit, Withdrawn
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Drotebanol.Approved
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Drotebanol.Approved, Vet Approved
HarmalineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Harmaline.Experimental
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Drotebanol.Approved, Illicit, Investigational
HexobarbitalThe risk or severity of adverse effects can be increased when Hexobarbital is combined with Drotebanol.Approved
HydracarbazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Hydracarbazine.Experimental
HydrocodoneDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.Approved, Illicit
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Drotebanol.Approved, Illicit
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved
IloperidoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Iloperidone.Approved
ImipramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Imipramine.Approved
IndalpineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Indalpine.Investigational, Withdrawn
IndiplonThe risk or severity of adverse effects can be increased when Drotebanol is combined with Indiplon.Investigational
IproclozideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Iproclozide.Withdrawn
IproniazidThe risk or severity of adverse effects can be increased when Drotebanol is combined with Iproniazid.Withdrawn
IsocarboxazidThe risk or severity of adverse effects can be increased when Drotebanol is combined with Isocarboxazid.Approved
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Drotebanol.Approved, Vet Approved
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Drotebanol.Approved, Vet Approved
KetazolamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ketazolam.Approved
KetobemidoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ketobemidone.Approved, Investigational
LamotrigineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Lamotrigine.Approved, Investigational
LevetiracetamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Levetiracetam.Approved, Investigational
LevobupivacaineThe risk or severity of adverse effects can be increased when Levobupivacaine is combined with Drotebanol.Approved, Investigational
LevocabastineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Levocabastine.Approved
LevocetirizineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Levocetirizine.Approved
LevodopaThe risk or severity of adverse effects can be increased when Drotebanol is combined with Levodopa.Approved
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Drotebanol.Approved, Investigational
LevomilnacipranThe risk or severity of adverse effects can be increased when Drotebanol is combined with Levomilnacipran.Approved
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Drotebanol.Approved
LidocaineThe risk or severity of adverse effects can be increased when Lidocaine is combined with Drotebanol.Approved, Vet Approved
LithiumThe risk or severity of adverse effects can be increased when Lithium is combined with Drotebanol.Approved
LofentanilThe risk or severity of adverse effects can be increased when Drotebanol is combined with Lofentanil.Illicit
LoprazolamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Loprazolam.Experimental
LoratadineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Loratadine.Approved
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Drotebanol.Approved
LormetazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Lormetazepam.Approved
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Drotebanol.Approved
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Drotebanol.Approved
Magnesium SulfateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Vet Approved
MaprotilineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Maprotiline.Approved
MebanazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Mebanazine.Withdrawn
MebicarThe risk or severity of adverse effects can be increased when Drotebanol is combined with Mebicar.Experimental
MeclizineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Meclizine.Approved
MedazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Medazepam.Experimental
MedetomidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Medetomidine.Vet Approved
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Drotebanol.Approved, Nutraceutical, Vet Approved
MelperoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Melperone.Approved, Investigational
MepivacaineThe risk or severity of adverse effects can be increased when Mepivacaine is combined with Drotebanol.Approved, Vet Approved
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Drotebanol.Approved, Illicit
MeptazinolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Meptazinol.Experimental
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Drotebanol.Approved, Investigational
MetaxaloneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Metaxalone.Approved
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Drotebanol.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Drotebanol.Approved, Illicit
MethapyrileneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methapyrilene.Withdrawn
MethaqualoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methaqualone.Illicit, Withdrawn
MethocarbamolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methocarbamol.Approved, Vet Approved
MethohexitalThe risk or severity of adverse effects can be increased when Methohexital is combined with Drotebanol.Approved
MethotrimeprazineDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.Approved
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Drotebanol.Approved, Investigational, Vet Approved
MethsuximideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methsuximide.Approved
MethylecgonineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methylecgonine.Experimental
Methylene blueThe risk or severity of adverse effects can be increased when Drotebanol is combined with Methylene blue.Approved, Investigational
MethylphenobarbitalThe risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Drotebanol.Approved
MetyrosineDrotebanol may increase the sedative activities of Metyrosine.Approved
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Drotebanol.Approved, Illicit
MilnacipranThe risk or severity of adverse effects can be increased when Drotebanol is combined with Milnacipran.Approved
MinaprineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Minaprine.Approved
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Investigational
MirtazapineDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.Approved
MoclobemideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Moclobemide.Approved
MolindoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Molindone.Approved
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Drotebanol.Approved, Investigational
NabiloneNabilone may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved, Investigational
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Drotebanol.Approved
NefazodoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Nefazodone.Approved, Withdrawn
NialamideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Nialamide.Withdrawn
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Drotebanol.Approved
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Drotebanol.Approved, Vet Approved
NorfluraneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Norflurane.Investigational
NormethadoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Normethadone.Approved, Illicit
NortriptylineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Nortriptyline.Approved
OctamoxinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Octamoxin.Withdrawn
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Drotebanol.Approved, Investigational
OlopatadineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Olopatadine.Approved
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Drotebanol.Approved
OpiumThe risk or severity of adverse effects can be increased when Drotebanol is combined with Opium.Approved, Illicit
OrphenadrineDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.Approved
OsanetantThe risk or severity of adverse effects can be increased when Drotebanol is combined with Osanetant.Investigational
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Drotebanol.Approved
OxethazaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Oxethazaine.Approved, Investigational
OxprenololThe risk or severity of adverse effects can be increased when Drotebanol is combined with Oxprenolol.Approved
OxybuprocaineThe risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Drotebanol.Approved
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Drotebanol.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Drotebanol.Approved, Investigational, Vet Approved
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Drotebanol.Approved
ParaldehydeDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.Approved, Investigational
PargylineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pargyline.Approved
ParoxetineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Paroxetine.Approved, Investigational
PenfluridolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Penfluridol.Experimental
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Drotebanol.Approved, Vet Approved
PentobarbitalThe risk or severity of adverse effects can be increased when Pentobarbital is combined with Drotebanol.Approved, Vet Approved
PerampanelPerampanel may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved
PerazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Perazine.Investigational
PerospironeThe risk or severity of adverse effects can be increased when Drotebanol is combined with Perospirone.Approved
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Drotebanol.Approved
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Drotebanol.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenazocine.Experimental
PhenelzineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenelzine.Approved
PhenibutThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenibut.Experimental
PheniprazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pheniprazine.Withdrawn
PhenobarbitalThe risk or severity of adverse effects can be increased when Phenobarbital is combined with Drotebanol.Approved
PhenoperidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenoperidine.Experimental
PhenoxyethanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenoxyethanol.Approved
PhenoxypropazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenoxypropazine.Withdrawn
PhenytoinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Phenytoin.Approved, Vet Approved
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Drotebanol.Approved
PipamperoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pipamperone.Approved, Investigational
PipotiazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pipotiazine.Approved, Investigational
PiritramideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Piritramide.Investigational
PirlindoleThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pirlindole.Approved
PivhydrazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pivhydrazine.Withdrawn
PizotifenThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pizotifen.Approved
PomalidomideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pomalidomide.Approved
PramipexoleDrotebanol may increase the sedative activities of Pramipexole.Approved, Investigational
PramocaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Pramocaine.Approved
PrazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Prazepam.Approved, Illicit
PregabalinThe risk or severity of adverse effects can be increased when Pregabalin is combined with Drotebanol.Approved, Illicit, Investigational
PrilocaineThe risk or severity of adverse effects can be increased when Prilocaine is combined with Drotebanol.Approved
PrimidoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Primidone.Approved, Vet Approved
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Drotebanol.Approved, Investigational, Vet Approved
ProcarbazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Procarbazine.Approved
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Drotebanol.Approved, Vet Approved
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Drotebanol.Approved, Vet Approved
PromethazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Promethazine.Approved
PropanididThe risk or severity of adverse effects can be increased when Drotebanol is combined with Propanidid.Experimental
ProparacaineThe risk or severity of adverse effects can be increased when Proparacaine is combined with Drotebanol.Approved, Vet Approved
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Drotebanol.Approved, Investigational, Vet Approved
PropoxycaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Propoxycaine.Approved
ProtriptylineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Protriptyline.Approved
ProxibarbalThe risk or severity of adverse effects can be increased when Drotebanol is combined with Proxibarbal.Experimental
PSD502The risk or severity of adverse effects can be increased when Drotebanol is combined with PSD502.Investigational
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Drotebanol.Approved, Illicit
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Drotebanol.Approved
QuinisocaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Quinisocaine.Experimental
RacloprideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Raclopride.Investigational
RamelteonThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ramelteon.Approved, Investigational
RasagilineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Rasagiline.Approved
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Drotebanol.Approved
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Drotebanol.Approved, Withdrawn
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Drotebanol.Approved, Investigational
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Drotebanol.Approved, Investigational
RitanserinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ritanserin.Investigational
RomifidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Romifidine.Vet Approved
RopiniroleDrotebanol may increase the sedative activities of Ropinirole.Approved, Investigational
RopivacaineThe risk or severity of adverse effects can be increased when Ropivacaine is combined with Drotebanol.Approved
RotigotineDrotebanol may increase the sedative activities of Rotigotine.Approved
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Drotebanol.Approved
SafrazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Safrazine.Withdrawn
ScopolamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Scopolamine.Approved
SecobarbitalThe risk or severity of adverse effects can be increased when Secobarbital is combined with Drotebanol.Approved, Vet Approved
SelegilineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Selegiline.Approved, Investigational, Vet Approved
SepranoloneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Sepranolone.Investigational
SertindoleThe risk or severity of adverse effects can be increased when Drotebanol is combined with Sertindole.Approved, Investigational, Withdrawn
SertralineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Sertraline.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Drotebanol.Approved, Vet Approved
Sodium oxybateSodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved
StiripentolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Stiripentol.Approved
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Drotebanol.Approved, Investigational
SulpirideThe risk or severity of adverse effects can be increased when Sulpiride is combined with Drotebanol.Approved, Investigational
SultoprideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Sultopride.Experimental
SuvorexantDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Approved
TandospironeThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tandospirone.Investigational
TapentadolTapentadol may increase the central nervous system depressant (CNS depressant) activities of Drotebanol.Approved
TasimelteonThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tasimelteon.Approved
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Drotebanol.Approved
TetrabenazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tetrabenazine.Approved
TetracaineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tetracaine.Approved, Vet Approved
TetrahydropalmatineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tetrahydropalmatine.Investigational
TetrodotoxinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tetrodotoxin.Investigational
ThalidomideDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.Approved, Investigational, Withdrawn
ThiamylalThe risk or severity of adverse effects can be increased when Thiamylal is combined with Drotebanol.Approved, Vet Approved
ThiopentalThe risk or severity of adverse effects can be increased when Thiopental is combined with Drotebanol.Approved, Vet Approved
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Drotebanol.Approved, Withdrawn
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Drotebanol.Approved
TiagabineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tiagabine.Approved
TiaprideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tiapride.Approved, Investigational
TiletamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tiletamine.Vet Approved
TilidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tilidine.Experimental
TizanidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tizanidine.Approved
TolcaponeThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tolcapone.Approved, Withdrawn
ToloxatoneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Toloxatone.Approved
TopiramateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Topiramate.Approved
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Drotebanol.Approved, Investigational
Trans-2-PhenylcyclopropylamineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Trans-2-Phenylcyclopropylamine.Experimental
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Drotebanol.Approved
TrazodoneThe risk or severity of adverse effects can be increased when Trazodone is combined with Drotebanol.Approved, Investigational
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Drotebanol.Approved
Tricaine methanesulfonateThe risk or severity of adverse effects can be increased when Drotebanol is combined with Tricaine methanesulfonate.Vet Approved
TrichloroethyleneThe risk or severity of adverse effects can be increased when Drotebanol is combined with Trichloroethylene.Approved
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Drotebanol.Approved
TrifluperidolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Trifluperidol.Experimental
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Drotebanol.Approved, Vet Approved
TrimipramineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Trimipramine.Approved
TriprolidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Triprolidine.Approved
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Drotebanol.Approved, Investigational
VenlafaxineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Venlafaxine.Approved
VeraliprideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Veralipride.Experimental
VigabatrinThe risk or severity of adverse effects can be increased when Drotebanol is combined with Vigabatrin.Approved
Vinyl etherThe risk or severity of adverse effects can be increased when Drotebanol is combined with Vinyl ether.Experimental
VortioxetineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Vortioxetine.Approved
XenonThe risk or severity of adverse effects can be increased when Drotebanol is combined with Xenon.Experimental
XylazineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Xylazine.Vet Approved
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Drotebanol.Approved, Illicit, Investigational
ZiconotideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Ziconotide.Approved
ZimelidineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Zimelidine.Withdrawn
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Drotebanol.Approved
ZolazepamThe risk or severity of adverse effects can be increased when Drotebanol is combined with Zolazepam.Vet Approved
ZolpidemDrotebanol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.Approved
ZonisamideThe risk or severity of adverse effects can be increased when Drotebanol is combined with Zonisamide.Approved, Investigational
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Drotebanol.Approved
ZotepineThe risk or severity of adverse effects can be increased when Drotebanol is combined with Zotepine.Approved, Investigational
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Drotebanol.Approved, Investigational
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Drug
D01496
PubChem Compound
6916258
PubChem Substance
46508971
ChemSpider
16736125
ChEBI
31951

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility2.15 mg/mLALOGPS
logP1.61ALOGPS
logP1.02ChemAxon
logS-2.2ALOGPS
pKa (Strongest Acidic)13.64ChemAxon
pKa (Strongest Basic)8.9ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area62.16 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity91.99 m3·mol-1ChemAxon
Polarizability36.19 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9595
Blood Brain Barrier+0.9381
Caco-2 permeable+0.7603
P-glycoprotein substrateSubstrate0.9255
P-glycoprotein inhibitor IInhibitor0.7512
P-glycoprotein inhibitor IINon-inhibitor0.8049
Renal organic cation transporterNon-inhibitor0.6121
CYP450 2C9 substrateNon-substrate0.8035
CYP450 2D6 substrateSubstrate0.5891
CYP450 3A4 substrateSubstrate0.8261
CYP450 1A2 substrateNon-inhibitor0.7566
CYP450 2C9 inhibitorNon-inhibitor0.8929
CYP450 2D6 inhibitorInhibitor0.565
CYP450 2C19 inhibitorNon-inhibitor0.8204
CYP450 3A4 inhibitorNon-inhibitor0.8353
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9743
Ames testNon AMES toxic0.8598
CarcinogenicityNon-carcinogens0.9544
BiodegradationNot ready biodegradable0.9837
Rat acute toxicity2.9617 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9108
hERG inhibition (predictor II)Inhibitor0.5102
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Classification
Not classified

Drug created on July 31, 2007 07:10 / Updated on December 01, 2017 14:45